Recently diagnosed with HIV? Click here

Immune responses to hepatitis B

Clinical trial • Unknown • 19 February 2010
The status of this trial is Unknown. Please check back on this page at a later date to see any updates, or contact us if you require further information about this trial.

About this trial

We're not sure why some people clear the hepatitis B virusA small infective organism which is incapable of reproducing outside a host cell. (HBVHepatitis B virus) from their bodies while others do not.

In this study, investigators will analyse how our white blood cells respond differently to HBV. They are using new tools that can tell precisely which component of the immune response may be different in people who are chronically infected with HBV versus those who are also infected with HIV.

Official title:Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural History
What is this trial studying?Other
Start date:2004

This may be the proposed or expected start date for trials which have not yet started.

How many participants will this trial enrol?104

The exact number of participants may be lower or slightly higher than this. Some trials also have specific quotas for participants from each state, city or clinic.

Links to further information:
Related trials:
Tags:hepatitis B

Who can enrol in this trial?

You may be eligible to participate in this trial if you meet the following criteria:

  • At least 18 years old
  • Positive test for active hepatitis B virus (HBV) infection

This is a summary of key inclusion and exclusion criteria for this trial. There may be other criteria which may exclude some people from participation in this trial. Some laboratory tests may also be required. Consult your doctor, or view the trial protocol or informed consent documentation to see the full range of exclusion and inclusion criteria.

Disclaimer

While NAPWA has taken every care to compile the information on this page and to keep it up-to-date, we cannot guarantee its correctness and completeness.

  • Before making the decision to participate in any clinical research, read our background information.
  • Email NAPWA if you have any questions or comments about this trial
Text size: font smallerfont normalfont larger print-friendly version of this pagePDF version of this pageemail this page to a friend

This Clinical trial was first published on 19 February 2010 — more than one year ago.

While the content of this clinical trial was checked for accuracy at the time of publication, NAPWA recommends checking to determine whether the information is the most up-to-date available, especially when making decisions which may affect your health.

This article may contain medical information. NAPWA makes every reasonable effort to ensure the information on this website is accurate, reliable and up-to-date, including obtaining technical reviews by medically-qualified reviewers, however the authors of information on this website are not qualified to give medical advice, except where explicitly stated.

The content of this website is intended to support, not replace, the relationship between people living with HIV/AIDS and their medical advisers, and is not intended as a substitute for medical advice.

Website links

HIV Clinical Trials update

Recently updated entries from the NAPWA Clinical Trials database.

more